A to Z Summary Results - Patient Decision Aids - Ottawa Hospital Research Institute 


Patient Decision Aid Summary

Title Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline.
To access it View the patient decision aid on the developer website
Audience Adults diagnosed with a patent foramen ovale (PFO) and cryptogenic stroke with no atrial fibrillation, no aortic disease, no left-sided heart disease, no cerebrovascular disease.
Options included PFO Closure.
Anticoagulants.
Antiplatelets.
Year of last update or review 2018
Format Web, paper, PDF, Magic App
Developer Ton Kuijpers
Where was it developed? t.kuijpers@nhg.org
BMJ
The Netherlands
Health condition Stroke
Language English
Based on 2025 IPDAS criteria (International Patient Decision Aid Standards) this patient decision aid (and/or supporting materials) meets:
7 out of 7 IPDAS Qualifying criteria to be defined as a patient decision aid
5 out of 7 IPDAS Essential criteria to lower the risk of making a biased decision
Not applicable: Other IPDAS Essential criteria for patient decision aids about screening or testing
View IPDAS criteria details.

Last modified: 2025-07-29.